SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Arsanis, Inc. Receives Grant from the Austrian Research Promotion Agency for Pre-Clinical and Clinical Development of Monoclonal Antibodies Against Severe Nosocomial Infections